About this item:

123 Views | 109 Downloads

Author Notes:

Christina F. Spiropoulou, PhD, Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS G14, Atlanta, GA 30333 (ccs8@cdc.gov

We thank the patients who participated in these studies; and the technical staff at the Emory University Hospital isolation unit; and other support staff that made this work possible.

Authors reported no conflicts of interest.

Subjects:

Research Funding:

This work was supported by the National Institutes of Health (loan repayment award to J. R. S. and grant K12 HD072245 to A. K. M); and Burroughs Wellcome (career award to A. K. M.).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Immunology
  • Infectious Diseases
  • Microbiology
  • Ebola
  • qRT-PCR
  • virus isolation
  • HEMORRHAGIC-FEVER
  • OUTBREAK
  • PROTECTION

Relationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation From Human Plasma

Tools:

Journal Title:

Journal of Infectious Diseases

Volume:

Volume 212, Number suppl 2

Publisher:

, Pages S346-S349

Type of Work:

Article | Final Publisher PDF

Abstract:

We performed a longitudinal analysis of plasma samples obtained from 4 patients with Ebola virus (EBOV) disease (EVD) to determine the relationship between the real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)-based threshold cycle (Ct) value and the presence of infectious EBOV. EBOV was not isolated from plasma samples with a Ct value of >35.5 or >12 days after onset of symptoms. EBOV was not isolated from plasma samples in which anti-EBOV nucleoprotein immunoglobulin G was detected. These data demonstrate the utility of interpreting qRT-PCR results in the context of the course of EBOV infection and associated serological responses for patient-management decisions.

Copyright information:

© 2015 Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

This is an Open Access work distributed under the terms of the Creative Commons Universal : Public Domain Dedication License (https://creativecommons.org/publicdomain/zero/1.0/).
Export to EndNote